Inventor · disambiguated record
Thomas Willem Johannes Huizinga
Also filed as: HUIZINGA THOMAS · HUIZINGA THOMAS WILLEM JOHANNES
4 granted patents·4 pending applications·4 citations·filing 2006–2024
66Inventor score
Top patents by PatentIndex Score
8 records- 0185US10078080B2Anti-carbamylated protein antibodies and the risk for arthritisACADEMISCH ZIEKENHUIS LEIDEN·Filed 2017·Granted Sep 18, 2018·2 cites·21 claims
- 0274US2025093350A1Fab-linked glycans as biomarker for the transition from a pre disease "at-risk-phase" to rheumatoid arthritis, aav or sjögren syndromeACADEMISCH ZIEKENHUIS LEIDEN·Filed 2024·Application pending·0 cites
- 0372US9632084B2Anti-carbamylated protein antibodies and the risk for arthritisTROUW LEENDERT ADRIANUS·Filed 2012·Granted Apr 25, 2017·2 cites·9 claims
- 0471US2020110087A1Anti-carbamylated protein antibodies and the risk for arthritisACADEMISCH ZIEKENHUIS LEIDEN·Filed 2019·Application pending·0 cites
- 0570US2021405047A1Anti-carbamylated protein antibodies and the risk for arthritisACADEMISCH ZIEKENHUIS LEIDEN·Filed 2021·Application pending·0 cites
- 0667US10539563B2Anti-carbamylated protein antibodies and the risk for arthritisACADEMISCH ZIEKENHUIS LEIDEN·Filed 2018·Granted Jan 21, 2020·0 cites·15 claims
- 0756US12158468B2Fab-linked glycans as biomarker for the transition from a pre-disease “at-risk-phase” to rheumatoid arthritis; AAV or Sjögren syndromeACADEMISCH ZIEKENHUIS LEIDEN·Filed 2017·Granted Dec 3, 2024·0 cites·9 claims
- 0843US2009117584A1Non-Human mammalian Arthritis Model Featuring Human Antibodies Against Citrul-Linated ProteinsGENMAB AS·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas Willem Johannes Huizinga files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →